Inventor

HESS GEORG

DE33 patents

⚠️ This page may combine multiple inventors who share the name “HESS GEORG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HESS GEORG

ROCHE DIAGNOSTICS OPERATIONS

NT-proBNP/troponin ratio for assessing myocardial dysfunction

Multimarker panel based on PIGF for diabetes types 1 and 2

Differentiation of cardiac and pulmonary causes of acute shortness of breath

Natriuretic peptides and placenta growth factor levels for risk stratification

Differentiation of acute and chronic myocardial necrosis in symptomatic patients

Diagnosing risk of cardiovascular complications using natiuretic peptides

NT-proANP and NT-proBNP for diagnosing cardiac diseases

Biochemical markers for acute pulmonary embolism

Diagnostic means and methods using troponin T and NT-proBNP

Cardiac troponin as an indicator of coronary artery disease

Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization

Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides

Methods for differentiation between cardiac and pulmonary causes of chronic dyspnea

Myoglobin as early predictor of myocardial infarction

HESS GEORG

L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy

Biochemical markers for acute pulmonary embolism

Monitoring myocardial infarction and its treatment

Biochemical markers for acute pulmonary embolism

Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1

H-FABP as early predictor of myocardial infarction

Identification of subjects being susceptible to anti-angiogenesis therapy

NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events

Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction

ROCHE DIAGNOSTICS OPERATIONS INC

Use of IGFBP-7 in the assessment of heart failure

Use of IGFBP-7 in the assessment of heart failure

Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure

GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients

Troponin and BNP based diagnosis of risk patients and cause of stroke

NT-proANP and NT-proBNP for the diagnosis of stroke

Prediction and recognition of acute kidney injury after surgery

WIENHUES-THELEN URSULA-HENRIKE

Use of SFRP-3 in the assessment of heart failure

Use of SLIM-1 in the assessment of heart failure

BLOCK DIRK

Use of mimecan in the assessment of heart failure